Subscribe
Sign in
Home
Events Roundup
Healthtech Pigeon
About us at SomX
Archive
About
Latest
Top
Discussions
#63 – Mind the mitochondria: biotech takes aim at Parkinson’s & ALS
The coffee break biotech roundup, by SomX.
Sep 13
2
#62 - Mind the mozzies: biotech bites back
The coffee break biotech roundup, by SomX.
Sep 6
1
August 2025
#61 - This little piggy had a transplant
The coffee break biotech roundup, by SomX.
Aug 30
1
#60 - New approvals, new models, new money
The coffee break biotech roundup, by SomX.
Aug 25
#59 - Cell-ebrate good times, come on!
The coffee break biotech roundup, by SomX.
Aug 18
#58 - Choc, stock and two smoking trials
The coffee break biotech roundup, by SomX.
Aug 9
1
#57 - AI sharpens up, Merck makes cuts & FDA yields
The coffee break biotech roundup, by SomX.
Aug 2
3
July 2025
#56 - Spud-tacular developments & starchy standoffs
The coffee break biotech roundup, by SomX.
Jul 26
2
#55 - Of mice, cats, and medicine
The coffee break biotech roundup, by SomX.
Jul 19
1
#54 - Moss-powered medicines & the next Moderna
The coffee break biotech roundup, by SomX.
Jul 12
1
#53 - All aboard the funding flight!
The coffee break biotech roundup, by SomX.
Jul 5
1
June 2025
#52 - Hydrogen snacks, metabolic acts & policy quacks
The coffee break biotech roundup, by SomX.
Jun 27
4
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
